Pfizer Inc. 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-05 6:12 pm Sale |
2024-08-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
0 0.000% |
-27,349,211 (Position Closed) |
Filing |
| 2023-10-18 4:27 pm Unchanged |
2023-10-12 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 15.400% |
0 (Unchanged) |
Filing |
| 2022-04-07 4:51 pm Unchanged |
2022-03-31 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 18.500% |
0 (Unchanged) |
Filing |
| 2021-09-17 4:27 pm Unchanged |
2021-09-10 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 18.900% |
0 (Unchanged) |
Filing |
| 2021-07-09 4:16 pm Unchanged |
2021-07-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 19.400% |
0 (Unchanged) |
Filing |
| 2020-11-06 4:10 pm Purchase |
2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 21.500% |
27,349,211 (New Position) |
Filing |